Literature DB >> 27890589

Aged mice receiving caffeine since adulthood show distinct patterns of anxiety-related behavior.

Paulo Henrique S Botton1, Daniela Pochmann1, Andreia S Rocha1, Fernanda Nunes1, Amanda S Almeida1, Daniela M Marques1, Lisiane O Porciúncula2.   

Abstract

Caffeine is the psychostimulant most consumed worldwide. Anxiogenic effects of caffeine have been described in adult animals with controversial findings about its anxiogenic potential. Besides, the effects of caffeine on anxiety with aging are still poorly known. In this study, adult mice (6months old) started to receive caffeine (0.3 and 1.0mg/mL, drinking water) during 12-14months only in the light cycle and at weekdays. The open field (OF) and elevated plus maze (EPM) testing were used to determine the effects of caffeine on anxiety-related behavior in adult and aged mice (18-20months old). Because aging alters synaptic proteins, we also evaluated SNAP-25 (as a nerve terminals marker), GFAP (as an astrocyte marker) and adenosine A1 and A2A receptors levels in the cortex. According to the OF analysis, caffeine did not change both hypolocomotion and anxiety with aging. However, aged mice showed less anxiety behavior in the EPM, but after receiving caffeine (0.3mg/mL) during adulthood they were anxious as adult mice. While SNAP-25 and adenosine A2A receptors increased with aging, both GFAP and adenosine A1 receptors were not affected. Caffeine at moderate dose prevented the age-related increase of the SNAP-25, with no effect on adenosine A2A receptors. The absence of effect for the highest dose suggests that tolerance to caffeine may have developed over time. Aged mice showed high responsiveness to the OF, being difficult to achieve any effect of caffeine. On the other hand this substance sustained the adult anxious behavior over time in a less stressful paradigm, and this effect was coincident with changes in the SNAP-25, suggesting the involvement of this synaptic protein in the ability of caffeine to preserve changes related to emotionality with aging.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenosine; Aging; Anxiety; Caffeine; Synaptic proteins

Mesh:

Substances:

Year:  2016        PMID: 27890589     DOI: 10.1016/j.physbeh.2016.11.030

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  5 in total

1.  Differential Behavioral and Biochemical Responses to Caffeine in Male and Female Rats from a Validated Model of Attention Deficit and Hyperactivity Disorder.

Authors:  Fernanda Nunes; Daniela Pochmann; Amanda Staldoni Almeida; Daniela Melo Marques; Lisiane de Oliveira Porciúncula
Journal:  Mol Neurobiol       Date:  2018-03-20       Impact factor: 5.590

2.  Acute effect of cola and caffeine on locomotor activity in drosophila and rat.

Authors:  K Kmeťová; M Marônek; V Borbélyová; J Hodosy; P Celec
Journal:  Physiol Res       Date:  2021-04-30       Impact factor: 1.881

3.  Are the 50's, the transition decade, in choroid plexus aging?

Authors:  Ana Tahira; Fernanda Marques; Helena Brentani; Joana Almeida Palha; Bianca Lisboa; Arthur Feltrin; André Barbosa; Kátia Cristina de Oliveira; Carlos Alberto de Bragança Pereira; Renata Leite; Lea Grinberg; Claudia Suemoto; Renata Eloah de Lucena Ferretti-Rebustini; Carlos Augusto Pasqualucci; Wilson Jacob-Filho
Journal:  Geroscience       Date:  2021-02-12       Impact factor: 7.581

4.  Lactobacillus paracasei PS23 Delays Progression of Age-Related Cognitive Decline in Senescence Accelerated Mouse Prone 8 (SAMP8) Mice.

Authors:  Shih-Yi Huang; Li-Han Chen; Ming-Fu Wang; Chih-Chieh Hsu; Ching-Hung Chan; Jia-Xian Li; Hui-Yu Huang
Journal:  Nutrients       Date:  2018-07-12       Impact factor: 5.717

5.  Genetically Determined Levels of Serum Metabolites and Risk of Neuroticism: A Mendelian Randomization Study.

Authors:  Li Qian; Yajuan Fan; Fengjie Gao; Binbin Zhao; Bin Yan; Wei Wang; Jian Yang; Xiancang Ma
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.